Sustained Tubulo-interstitial Protection in SHRs by Transient Losartan Treatment: An Effect of Decelerated Aging?

Background Hypertensive target organ damage shows characteristics of accelerated cell turnover and aging. This might have developed during the evolution of hypertension. In the kidney, high cell turnover is mainly restricted to tubular cells. It was the aim of this study to investigate whether a tra...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of hypertension Vol. 21; no. 2; pp. 177 - 182
Main Authors Baumann, Marcus, Bartholome, Roger, Peutz-Kootstra, Carine J., Smits, Jos F.M., Struijker-Boudier, Harry A.J.
Format Journal Article
LanguageEnglish
Published New York, NY Oxford University Press 01.02.2008
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Hypertensive target organ damage shows characteristics of accelerated cell turnover and aging. This might have developed during the evolution of hypertension. In the kidney, high cell turnover is mainly restricted to tubular cells. It was the aim of this study to investigate whether a transient intervention in spontaneously hypertensive rats (SHRs) leads to reduced tubular cell turnover and attenuates the renal aging process and tubulo-interstitial damage in the long-term. Methods SHRs (i) were prehypertensively (weeks 4–8) treated with losartan (ii) or hydralazine (iii) (20 and 4 mg/kg/day, respectively) and compared to Wistar-Kyoto (WKY) rats (iv). Groups were investigated at weeks 8 and 72 (except iii). At both time points tubular cell proliferation (proliferative cell nuclear antigen) and systolic blood pressure (SBP) were evaluated. At week 72, aging parameters such as telomere length were assessed. Renal damage was semiquantitatively assessed (scale: 0–4) by measuring the parenchyma (atrophy) and vasculature (media thickness). Results Treatments equipotently reduced SBP in young SHRs (P < 0.01) but only losartan reduced renal proliferation (proliferative cell nuclear antigen: (i) 2.8 ± 0.8, (ii) 1.3 ± 0.3, (iii) 3.0 ± 0.6, (iv) 0.1 ± 0.1 cells/mm2). In SHRs treated with losartan(SHR-Los) tubular proliferation remained reduced and renal telomere length was significantly greater than in untreated SHRs (fold: (i) 1.0 ± 0.1, (ii) 2.8 ± 0.3, P < 0.01). Untreated SHRs (median 2.0, range 1–3; P < 0.007), but not SHR-Los (median 1.0, range 0–2; P = 0.06) demonstrated more tubular atrophy than WKY rats (median 0.5, range 0–1). Conclusions Transient losartan treatment reduces cell-turnover not only acutely but also for a prolonged period after drug withdrawal. This results in the long-term in reduced aging and attenuated tubulo-interstitial damage, suggesting there exists a modulating effect of angiotensin II (ANGII)-antagonism on long-term cell turnover.
Bibliography:href:21_2_177.pdf
istex:AC58DFC4BD1AE2DA88D994F82BA60DDBD59A118E
ark:/67375/HXZ-26RH4J60-7
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0895-7061
1879-1905
1941-7225
DOI:10.1038/ajh.2007.30